Neprilysin inhibition (NEPI) enhances the activity of natriuretic peptide systems causing subsequent natriuresis, diuresis, and inhibition of the RAAS, acting as a significantly beneficial counter-regulatory system in conditions of RAAS activation such as chronic heart failure and CKD. The gene discussed is MME; the disease is chronic kidney disease.